Akari Therapeutics (AKTX) Net Income Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 32.79% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 60.43% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -46.86% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 13.80% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 19.97% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -3.84% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 47.10% |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -46.86% |
| Jun 30, 2025 | 18.31% |
| Mar 31, 2025 | 11.92% |
| Dec 31, 2024 | 94.31% |
| Sep 30, 2024 | -25.57% |
| Jun 30, 2024 | -20.10% |
| Mar 31, 2024 | -2.59% |
| Dec 31, 2023 | 9.64% |
| Sep 30, 2023 | -117.91% |
| Jun 30, 2023 | 8.11% |
| Mar 31, 2023 | 2.51% |
| Jun 30, 2022 | 1.22% |
| Mar 31, 2022 | -635.27% |
| Dec 31, 2021 | -1,531.90% |
| Sep 30, 2021 | 20.59% |
| Jun 30, 2021 | 18.21% |
| Mar 31, 2021 | -9.35% |
| Dec 31, 2020 | 20.20% |
| Sep 30, 2020 | 69.51% |
| Jun 30, 2020 | 6.84% |
| Mar 31, 2020 | 15.77% |
| Dec 31, 2019 | -39.46% |
| Sep 30, 2019 | -25.57% |
| Jun 30, 2019 | 7.02% |
| Mar 31, 2019 | 26.09% |
| Dec 31, 2018 | -27.87% |
| Sep 30, 2018 | 60.87% |
| Jun 30, 2018 | -67.92% |
| Mar 31, 2018 | -35.71% |
| Dec 31, 2017 | -130.04% |
| Sep 30, 2017 | -236.40% |
| Jun 30, 2017 | -48.58% |
| Mar 31, 2017 | -67.96% |